MAPT and Alzheimer disease: In vivo and in vitro studies using different Aβ and Tau pathology models, along with two-photon spectroscopy studies, transcriptomic analyses and single cell mRNA sequencing studies have highlighted a possible role for microglia activation and priming in driving the progression of early to late AD.